SDEV
Price:
$0.8682
Market Cap:
$43.80M
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Industry
Medical - Pharmaceuticals
IPO Date
2007-10-26
Stock Exchange
NYSE
Ticker
SDEV
According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 789.69%. This represents a change of 683.77% compared to the average of 100.76% of the last 4 quarters.
The mean historical ROE of NovaBay Pharmaceuticals, Inc. over the last ten years is 638.36%. The current 789.69% ROE has changed 23.71% with respect to the historical average. Over the past ten years (40 quarters), SDEV's ROE was at its highest in in the December 2024 quarter at 939.53%. The ROE was at its lowest in in the March 2024 quarter at -2008.75%.
Average
638.36%
Median
-116.31%
Minimum
-992.60%
Maximum
5.60%
Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 651.31%
Maximum Annual ROE = 5.60%
Minimum Annual Increase = -3119.66%
Minimum Annual ROE = -992.60%
| Year | ROE | Change |
|---|---|---|
| 2025 | 2.81% | -49.77% |
| 2024 | 5.60% | -3119.66% |
| 2023 | -185.43% | 84.48% |
| 2022 | -100.51% | 75.53% |
| 2021 | -57.26% | -36.10% |
| 2020 | -89.62% | -90.97% |
| 2019 | -992.60% | 651.31% |
| 2018 | -132.12% | -53.71% |
| 2017 | -285.39% | 54.10% |
| 2016 | -185.20% | -149.76% |
The current ROE of NovaBay Pharmaceuticals, Inc. (SDEV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.74%
5-year avg
1.61%
10-year avg
638.36%
NovaBay Pharmaceuticals, Inc.’s ROE is
| Company | ROE | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NovaBay Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the highest ROE for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the 3-year average ROE for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the 5-year average ROE for NovaBay Pharmaceuticals, Inc. (SDEV)?
How does the current ROE for NovaBay Pharmaceuticals, Inc. (SDEV) compare to its historical average?